Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis x

Linnea Chap, Stephen D. Nimer

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Low dose radiotherapy has been used to treat a variety of benign disorders including Histiocytosis X. Ionizing radiation may be leukemogenic with leukemia developing between 3.5 to 11 years after exposure. Twenty to 30% of these leukemias are chronic myelogenous leukemia (CML). In this report the rare development of PH1 + CML 11 years after radiation therapy for Histiocytosis X is recorded.

Original languageEnglish (US)
Pages (from-to)315-316
Number of pages2
JournalLeukemia and Lymphoma
Volume12
Issue number3-4
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Keywords

  • CML
  • Histiocytic disorders
  • Histiocytosis X
  • Radiation-induced malignancies

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis x'. Together they form a unique fingerprint.

  • Cite this